The 12 closest competitors and alternatives to DeepCyte Inc. among biotechnology companies — ranked by similarity to what DeepCyte Inc. actually does, not by market-cap band.
Subscribe to see DeepCyte Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
DeepCyte Inc. is an AI-powered biotechnology and toxicology platform headquartered in Wilmington, Delaware. Established in 2025, the company develops advanced computational tools for toxicity assessment and life sciences research.
DeepCyte Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $1.4M in January 2026. Xcout tracks 8 named people at DeepCyte Inc., including Theodore Alexandrov (CEO).
2 more named people on record for DeepCyte Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $1.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to DeepCyte Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Deep Cell Industries Inc. provides an AI-integrated platform called REM-I that combines label-free imaging, deep learning, and cell enrichment for single-cell morpholomic analysis. The company serves researchers and organizations in oncology, drug discovery, cell and gene therapy, and related life science fields by enabling high-resolution profiling and sorting of viable cells.
Similar biotechnology company
シンクサイト株式会社(ThinkCyte)は、AIと光学技術を組み合わせた高次元細胞解析技術「ゴーストサイトメトリー」を開発する日本のバイオテクノロジー企業です。製薬企業、研究機関、臨床・診断分野などに向けて、創薬研究や細胞分析のための装置・ソリューションを提供しています。
Biotech
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Similar biotechnology company
CytoTronics is a biotechnology research company headquartered in Boston, Massachusetts, specializing in cell-based discovery and high-density electrode array technology.
Similar biotechnology company
iOrganBio is a biotechnology company founded in 2024 that develops AI-powered platforms for the precision engineering and manufacturing of human cells and organoids. The company's CellForge platform aims to create reproducible human cell models for research applications, including cardiac disease studies and biological simulation.
Life Sciences
INDIGO Biosciences, Inc. provides life science solutions, specializing in in vitro cell-based reporter assay systems and screening services for pharmaceutical and research markets. Headquartered in State College, Pennsylvania, the company supports environmental, toxicological, and drug discovery testing.
Biotech, Life Sciences & TechBio
Kytopen Corp. is a biotechnology company focused on cell therapy discovery, with facilities located in Cambridge, Massachusetts, and Louisville, Colorado, as well as an international expansion in Germany.
Biotech
Adaptyv Biosystems operates an automated cloud laboratory that provides protein testing and validation services for protein designers and AI-first engineering teams. The company allows users to submit protein sequences digitally and delivers experimental data such as binding affinity, expression, and thermostability measurements.
Life Sciences
Danu Insights Ltd provides an AI-driven platform designed to optimize experiments for the life sciences sector, serving industries ranging from biotechnology to clinical research. The company's technology aims to help organizations improve experiment outcomes and accelerate research and development.
Biotech
InSphero provides 3D in vitro cell culture models, microplates, organ-on-a-chip platforms, and related services for drug discovery and safety testing. The company serves pharmaceutical, biotechnology, and research organizations seeking non-animal testing alternatives to evaluate drug efficacy, liver safety, oncology, and other complex diseases.
Healthtech
Benchling, Inc. is a Delaware corporation located in San Francisco, California, providing a life sciences R&D cloud software platform.
Healthtech
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for DeepCyte Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →